CAMPSQ19224
Title : Gaegurin 5
Source : Synthetic construct
PubMed : 22644847
Activity : Antibacterial
Gram Nature : Gram+, Gram-
Target :
Bacillus subtilis ATCC 6633[MIC = 3.1 microg/ml], Micrococcus luteus ATCC 10240[MIC = 3.1 microg/ml], Staphylococcus aureus ATCC 6538P[MIC = 6.3 microg/ml], Staphylococcus epidermidis ATCC 12228[MIC = 6.3 microg/ml], Escherichia coli ATCC 25922[MIC = 12.5 microg/ml], Shigella dysenteriae ATCC 9752[MIC = 25 microg/ml], Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028[MIC = 50 microg/ml], Klebsiella pneumoniae ATCC 10031[MIC = 12.5 microg/ml], Pseudomonas aeruginosa ATCC 27853[MIC = 12.5 microg/ml], Human renal carcinoma A498[IC50 = 21.48 microM], Human lung carcinoma A549[IC50 = 14.53 microM], Human colon adenocarcinoma HCT 116[IC50 = 14.8 microM], Human gastric cancer MKN 45[IC50 = 22.51 microM], Human prostate adenocarcinoma PC-3[IC50 = 29.1 microM], Human skin melanoma SK-MEL-2[IC50 = 22.25 microM], Human ovarian adenocarcinoma SK-OV-3[IC50 = 12.55 microM]
Validated : Experimentally Validated
Comment : Has anticancer activity
Length : 11
Sequence:
FLKWLFKWAKK

| © 2022, Biomedical Informatics Centre, ICMR-NIRRCH |
ICMR-National Institute for Research in Reproductive and Child Health, Jehangir Merwanji Street, Parel, Mumbai-400012
Maharashtra, India